However, HTS treatment of preparations incubated with CFTRinh172 was unaffected by the NK-1 blocker (Fig. 4E), indicating that the substance P-mediated HTS-triggered effect is CFTR-dependent and may be absent in CF airways. Here, TAC1 is linked to cystic fibrosis.